These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 18005449

  • 1. Item response analysis of the Positive and Negative Syndrome Scale.
    Santor DA, Ascher-Svanum H, Lindenmayer JP, Obenchain RL.
    BMC Psychiatry; 2007 Nov 15; 7():66. PubMed ID: 18005449
    [Abstract] [Full Text] [Related]

  • 2. Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS).
    Khan A, Lewis C, Lindenmayer JP.
    BMC Psychiatry; 2011 Nov 16; 11():178. PubMed ID: 22087503
    [Abstract] [Full Text] [Related]

  • 3. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G, Noisette C, Legrand A, Delahousse J.
    Encephale; 1997 Nov 16; 23(1):10-8. PubMed ID: 9172962
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.
    J Clin Psychiatry; 2002 Oct 16; 63(10):931-5. PubMed ID: 12416603
    [Abstract] [Full Text] [Related]

  • 5. [Influence of resistance to voices on depression].
    Monestès JL, Vavasseur-Desperriers J, Villatte M, Denizot L, Loas G, Rusinek S.
    Encephale; 2015 Feb 16; 41(1):25-31. PubMed ID: 24815790
    [Abstract] [Full Text] [Related]

  • 6. The multidimensional measurement of the positive symptoms of psychosis.
    Steel C, Garety PA, Freeman D, Craig E, Kuipers E, Bebbington P, Fowler D, Dunn G.
    Int J Methods Psychiatr Res; 2007 Feb 16; 16(2):88-96. PubMed ID: 17623388
    [Abstract] [Full Text] [Related]

  • 7. The heterogeneity of antipsychotic response in the treatment of schizophrenia.
    Case M, Stauffer VL, Ascher-Svanum H, Conley R, Kapur S, Kane JM, Kollack-Walker S, Jacob J, Kinon BJ.
    Psychol Med; 2011 Jun 16; 41(6):1291-300. PubMed ID: 20925971
    [Abstract] [Full Text] [Related]

  • 8. Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
    Feldman PD, Kaiser CJ, Kennedy JS, Sutton VK, Tran PV, Tollefson GD, Zhang F, Breier A.
    J Clin Psychiatry; 2003 Sep 16; 64(9):998-1004. PubMed ID: 14628974
    [Abstract] [Full Text] [Related]

  • 9. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.
    Arch Gen Psychiatry; 2006 Jun 16; 63(6):622-9. PubMed ID: 16754835
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ.
    J Clin Psychiatry; 2004 Dec 16; 65(12):1624-33. PubMed ID: 15641867
    [Abstract] [Full Text] [Related]

  • 11. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C, Auquier P, Llorca PM, Martinez JL, Bougerol T, Scotto JC.
    Encephale; 1997 Dec 16; 23(1):1-9. PubMed ID: 9172961
    [Abstract] [Full Text] [Related]

  • 12. The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis.
    Drake R, Haddock G, Tarrier N, Bentall R, Lewis S.
    Schizophr Res; 2007 Jan 16; 89(1-3):119-22. PubMed ID: 17095193
    [Abstract] [Full Text] [Related]

  • 13. [The PANSS (Positive And Negative Symptom) Scale].
    Guelfi JD.
    Encephale; 1997 Apr 16; 23 Spec No 2():35-8. PubMed ID: 9273305
    [Abstract] [Full Text] [Related]

  • 14. An excitement subscale of the Positive and Negative Syndrome Scale.
    Lindenmayer JP, Brown E, Baker RW, Schuh LM, Shao L, Tohen M, Ahmed S, Stauffer VL.
    Schizophr Res; 2004 Jun 01; 68(2-3):331-7. PubMed ID: 15099614
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X, Savage R, Borisov A, Rosenberg J, Woolwine B, Tucker M, May R, Feldman J, Nemeroff CB, Miller AH.
    J Psychiatr Res; 2006 Oct 01; 40(7):669-76. PubMed ID: 16762371
    [Abstract] [Full Text] [Related]

  • 16. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD, Andersen SW.
    J Clin Psychiatry; 1999 Oct 01; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [Abstract] [Full Text] [Related]

  • 17. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J, Gavrilidis E, Gwini SM, Worsley R, Grigg J, Warren A, Gurvich C, Gilbert H, Berk M, Davis SR.
    JAMA Psychiatry; 2016 Sep 01; 73(9):947-54. PubMed ID: 27438995
    [Abstract] [Full Text] [Related]

  • 18. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
    Furukawa TA, Levine SZ, Tanaka S, Goldberg Y, Samara M, Davis JM, Cipriani A, Leucht S.
    JAMA Psychiatry; 2015 Jan 01; 72(1):14-21. PubMed ID: 25372935
    [Abstract] [Full Text] [Related]

  • 19. [Subjective view of positive symptoms and quality of life in patients with schizophrenia].
    Karow A, Schäfer I, Hirdes F, Osterwald C, Naber D.
    Psychiatr Prax; 2008 Sep 01; 35(6):286-93. PubMed ID: 18504688
    [Abstract] [Full Text] [Related]

  • 20. Scales to measure dimensions of hallucinations and delusions: the psychotic symptom rating scales (PSYRATS).
    Haddock G, McCarron J, Tarrier N, Faragher EB.
    Psychol Med; 1999 Jul 01; 29(4):879-89. PubMed ID: 10473315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.